The EndoCompass Project
Research Roadmap for Better Hormone Health
The Goal
The goal of the EndoCompass project is to create opportunities for the pioneers of endocrine science — because their success means better endocrine health for all.
The EndoCompass Roadmap is set to outline the specific research needs and opportunities in areas of endocrine health and disease that, when addressed in future research calls and funding programs, will contribute to better health in Europe. The first audience are going to be European and national research and health policymakers and funding bodies, the leading sources of research funding in Europe.
We also anticipate additional benefits from this project:
- Articulating the research priorities in service of other funding mechanisms
- Demonstrating the attractiveness of research in endocrinology to young researchers
- Aligning the endocrine community around a common vision of research priorities
- Identifying clinical priorities
- Crafting a clear vision for other stakeholders around areas of high medical need and development opportunities
The Community
From the start, EndoCompass was envisioned as a collaborative effort, and the project structure reflects that. EndoCompass is jointly led by the European Society of Endocrinology (ESE) and the European Society for Paediatric Endocrinology (ESPE), extending the perspective of endocrinology across the lifetime.
We have also partnered up with specialist organisations sharing the same goal of excellence in endocrine science, with the aim to cover as much of the full scope of endocrinology as possible.
The development and writing of the research roadmap will rely on a wide inclusion of clinical, translational and basic science experts engaged with the participating societies. The unprecedented scope, the whole of endocrinology, requires a wide range of expertise throughout the research pipeline, from biochemists and molecular biologists, to clinician researchers and epidemiologists.
However, even this may prove insufficient to cover areas like endocrine-disrupting chemicals (EDCs) and artificial intelligence (AI). To cover these transversal areas, we are reaching out to external researchers pushing the envelope in these topics, who will work on the roadmap for these areas, as well as provide insight to other experts around interplay of transversal areas and endocrinology.
The Patient Voice
In the end, the success of EndoCompass hinges on the inclusion of those most directly affected — the patients. We recognise the vital role that patients' voice plays in understanding the real-world effects of endocrine disorders. That's why we have engaged a number of Patient Advocacy Groups and individuals, who will be working closely with researchers and clinical experts on deciding the research priorities that address their lived experiences.
The Output
The final deliverables of the project will be:
1. Detailed research roadmaps for different areas of endocrine science, ultimately released as one or several scientific publications - the main publication will be open access, published in the European Journal of Endocrinology (EJE)
2. A research and health policy-oriented summary that outlines to policy and funding stakeholders how investment in research in endocrinology can provide high societal returns
3. A communication and outreach platform for respective target audiences
This page will be continually updated with new information about the project, following along with its development in real time.
The research project is being developed under the supervision of the EndoCompass Steering Group, consisting of the presidents and representatives of ESE and ESPE. EASO and endo-ERN as General Partners are represented as well. Day-to-day management of the project is under the joint responsibility of the ESE and ESPE Clinical and Science Committees, and project management resources are provided by the ESE Office.
If you want to get involved in crafting the vision for the future of endocrine research, you can contact the Roadmap project manager, Srđan Pandurević.
|
Martin Fassnacht, ESE co-lead |
|
Eleanor Davies, ESE co-lead |
|
Martine Cools, ESPE co-lead |
|
Evelien Gevers ESPE co-lead |
|
Anita Hokken |
|
Jérôme Bertherat |
|
Martin Reincke |
|
Robin Peeters |
|
Simona Glasberg |
|
Felix Beuschlein |
|
Cynthia Andoniadou |
|
Anton Luger |
|
Alberto Pereira |
|
Volkan Yumuk |
|
Jonathan Mertens |
Adrenal and Cardiovascular Endocrinologyleaders: Guillaume Assie, Eystein Husebye, Nils Krone, and Maria-Cristina Zennaro |
Bone and Calcium Endocrinologyleaders: Wolfgang Högler, Katharina Jähn-Rickert, and Peter Kamenicky |
Cancer and Endocrinologyleaders: Jason Carroll, Cecilia Follin, Raul Luque, Hanneke van Santen, and Annemarie Verrijn Stuart |
Diabetes and Obesityleaders: Chantal Mathieu, Uberto Pagotto, Liesbeth van Rossum, and Martin Wabitsch Hyperinsulinism topic leader: Indi Banerjee |
Growthleaders: Anita Hokken-Koelega, Maité Tauber |
Pituitary Endocrinology and Neuroendocrine Tumorsleaders: Justo Castano, Mehul Dattani, Simona Glasberg, Niki Karavitaki, and Marianne Pavel |
Reproductive and Developmental Endocrinologyleaders: Martine Cools, Anders Juul, Csilla Krausz, and Đuro Macut |
Thyroid Endocrinologyleaders: Rosella Elisei, Juliane Leger, Agnieszka Piekiełko-Witkowska |
Transversal: Environmental Endocrinologyleaders: Anna Maria Andersson, Stefano Cianfarani, and Josef Köhrle |
Transversal: Rare Diseasesleaders: Olaf Hiort and Alberto Pereira |
Transversal: Endocrinology through Lifetimeleaders: Martine Cools, AJ van der Lelij |
Transversal: Artificial Intelligenceleaders: Guillaume Assie, Gustavo Carneiro |
Project jointly led by:
Project Partners:
